APA (7th ed.) Citation

T, A., K, K., T, M., A, T., K, T., K, E., . . . A, K. (2026). Interstitial lung disease constitutes a significant treatment burden in patients with rheumatoid arthritis. Frontiers in medicine, 13, 1756931. https://doi.org/10.3389/fmed.2026.1756931

Chicago Style (17th ed.) Citation

T, Aramaki, Kojima K, Michituji T, Takatani A, Terada K, Eguchi K, Ueki Y, Iwamoto N, and Kawakami A. "Interstitial Lung Disease Constitutes a Significant Treatment Burden in Patients with Rheumatoid Arthritis." Frontiers in Medicine 13 (2026): 1756931. https://doi.org/10.3389/fmed.2026.1756931.

MLA (9th ed.) Citation

T, Aramaki, et al. "Interstitial Lung Disease Constitutes a Significant Treatment Burden in Patients with Rheumatoid Arthritis." Frontiers in Medicine, vol. 13, 2026, p. 1756931, https://doi.org/10.3389/fmed.2026.1756931.